Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C13H11N3O |
| Molecular Weight | 225.2459 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC=C(O)C(=C1)N2N=C3C=CC=CC3=N2
InChI
InChIKey=MCPKSFINULVDNX-UHFFFAOYSA-N
InChI=1S/C13H11N3O/c1-9-6-7-13(17)12(8-9)16-14-10-4-2-3-5-11(10)15-16/h2-8,17H,1H3
| Molecular Formula | C13H11N3O |
| Molecular Weight | 225.2459 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/18569163Curator's Comment: The description was created based on several sources, including
https://clinicaltrials.gov/ct2/show/NCT01695356 | https://www.ncbi.nlm.nih.gov/pubmed/23075132
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18569163
Curator's Comment: The description was created based on several sources, including
https://clinicaltrials.gov/ct2/show/NCT01695356 | https://www.ncbi.nlm.nih.gov/pubmed/23075132
Drometrizole is a benzotriazole derivative used as an ultraviolet (UV) light absorber and stabilizer in cosmetics. Drometrizole is used widely as a UV absorber and stabilizer in plastics, polyesters, celluloses, acrylates, dyes, rubber, synthetic and natural fibers, waxes, detergent solutions, and orthodontic adhesives. It is similarly used in agricultural products and insecticides. Drometrizole is approved as an indirect food additive for use as an antioxidant and/or stabilizer in polymers. Short-term studies using rats reported liver weight increases, increases in the activities of enzymes aminopyrine N-demethylase, and UDP glucuronosyl- transferase, but no significant effects were noted in the activities of acid hydrolases or in hepatocyte organelles. Drometrizole and products containing Drometrizole were nontoxic in acute oral, inhalation, and dermal studies using animals. Although there are case reports in which Drometrizole was considered the sensitizing agent, clinical tests of cosmetic products containing 0.03% to 1.0% Drometrizole produced no irritation, sensitization, photosensitization, or phototoxicity in a total of 436 subjects.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: GO:0016039 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18569163 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Preventing | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Bis[2-(2H-benzotriazol-2-yl)-4-methylphenolato]palladium(II). | 2009-05-07 |
|
| [Synthesis and spectra of novel metal complexes of multi-nitrogen heterocyclic ligand]. | 2008-11 |
|
| Zinc complex based on 2-(5-methyl-2-hydroxyphenyl)benzotriazole: synthesis and electroluminescence characteristics. | 2008-10 |
|
| Mode-selective O-H stretching relaxation in a hydrogen bond studied by ultrafast vibrational spectroscopy. | 2006-08-21 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18569163
In a 2-year feeding study using rats, a NOEL of 47 to 58 mg/kg/day was reported.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/23075132
he inhibition of EBV-EA activation was assayed using the EBV genome carrying lymphoblastoid Raji cells of human origin, which were cultivated in RPMI 1640 medium. The cells were incubated at 370 C for 48 h in 1 mL of the medium containing butyric acid (4 mM, as co-inducer), TPA (20 ng/mL, 32 pM) and a known amount of test compound (Drometrizole) in DMSO. Smears were made from cell suspension. The EBV-EA-expressing cells were stained with high titre EBV-EA-positive serum from nasopharyngeal carcinoma patients and detected by an indirect immunofluorescence technique. In each assay, 500 cells were counted, and the experiments were carried out in triplicate. The average EA induction was compared to that of a positive control experiment with butyric acid (4 mM) and TPA (32 pM).
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:07:06 GMT 2025
by
admin
on
Mon Mar 31 18:07:06 GMT 2025
|
| Record UNII |
5X93W9OFZL
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C851
Created by
admin on Mon Mar 31 18:07:06 GMT 2025 , Edited by admin on Mon Mar 31 18:07:06 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1426903
Created by
admin on Mon Mar 31 18:07:06 GMT 2025 , Edited by admin on Mon Mar 31 18:07:06 GMT 2025
|
PRIMARY | RxNorm | ||
|
C77133
Created by
admin on Mon Mar 31 18:07:06 GMT 2025 , Edited by admin on Mon Mar 31 18:07:06 GMT 2025
|
PRIMARY | |||
|
C401764
Created by
admin on Mon Mar 31 18:07:06 GMT 2025 , Edited by admin on Mon Mar 31 18:07:06 GMT 2025
|
PRIMARY | |||
|
5X93W9OFZL
Created by
admin on Mon Mar 31 18:07:06 GMT 2025 , Edited by admin on Mon Mar 31 18:07:06 GMT 2025
|
PRIMARY | |||
|
CHEMBL1564747
Created by
admin on Mon Mar 31 18:07:06 GMT 2025 , Edited by admin on Mon Mar 31 18:07:06 GMT 2025
|
PRIMARY | |||
|
219-470-5
Created by
admin on Mon Mar 31 18:07:06 GMT 2025 , Edited by admin on Mon Mar 31 18:07:06 GMT 2025
|
PRIMARY | |||
|
DTXSID1027479
Created by
admin on Mon Mar 31 18:07:06 GMT 2025 , Edited by admin on Mon Mar 31 18:07:06 GMT 2025
|
PRIMARY | |||
|
m4766
Created by
admin on Mon Mar 31 18:07:06 GMT 2025 , Edited by admin on Mon Mar 31 18:07:06 GMT 2025
|
PRIMARY | Merck Index | ||
|
2440-22-4
Created by
admin on Mon Mar 31 18:07:06 GMT 2025 , Edited by admin on Mon Mar 31 18:07:06 GMT 2025
|
PRIMARY | |||
|
4717
Created by
admin on Mon Mar 31 18:07:06 GMT 2025 , Edited by admin on Mon Mar 31 18:07:06 GMT 2025
|
PRIMARY | |||
|
100000081024
Created by
admin on Mon Mar 31 18:07:06 GMT 2025 , Edited by admin on Mon Mar 31 18:07:06 GMT 2025
|
PRIMARY | |||
|
91885
Created by
admin on Mon Mar 31 18:07:06 GMT 2025 , Edited by admin on Mon Mar 31 18:07:06 GMT 2025
|
PRIMARY | |||
|
SUB06406MIG
Created by
admin on Mon Mar 31 18:07:06 GMT 2025 , Edited by admin on Mon Mar 31 18:07:06 GMT 2025
|
PRIMARY | |||
|
1228009
Created by
admin on Mon Mar 31 18:07:06 GMT 2025 , Edited by admin on Mon Mar 31 18:07:06 GMT 2025
|
PRIMARY | |||
|
3166
Created by
admin on Mon Mar 31 18:07:06 GMT 2025 , Edited by admin on Mon Mar 31 18:07:06 GMT 2025
|
PRIMARY | |||
|
17113
Created by
admin on Mon Mar 31 18:07:06 GMT 2025 , Edited by admin on Mon Mar 31 18:07:06 GMT 2025
|
PRIMARY | |||
|
5X93W9OFZL
Created by
admin on Mon Mar 31 18:07:06 GMT 2025 , Edited by admin on Mon Mar 31 18:07:06 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |